The European Commission has mentioned that it may start requiring all data-rich merger to seek approval rather than continuing with current guidelines which require approval only for mergers where the annual turnover of the combined businesses exceeds specified thresholds.
One current deal that seems to be spurring these considerations is the acquisition of the online careers site LinkedIn by Microsoft.
Salesforce, a leading opponent of the deal, is also suggesting to regulators that Microsoft will create proprietary bundles of its services and LinkedIn data.
Data in all forms seems valuable right now, because rich and varied data is at the core of machine learning and artificial intelligence, the basis for analyzing and predicting almost any action that can be digitally measured.
Essentially, the people are proposing judging anti-competitiveness on the basis of something with imputed value, the uses of which aren’t fully understood yet.
Full Content: The New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas